1 / 20

Leucemia Granulocítica Cronica

Leucemia Granulocítica Cronica. Dr. David Gómez Almaguer Hospital Universitario UANL Monterrey N.L. México. Enfermedades mieloproliferativas clonales de células hematopoyéticas. Wintrobe 1999. p 2342-2365. Leucemia Granulocítica.

remedios-graves
Download Presentation

Leucemia Granulocítica Cronica

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Leucemia Granulocítica Cronica Dr. David Gómez Almaguer Hospital Universitario UANL Monterrey N.L. México

  2. Enfermedades mieloproliferativas clonales de células hematopoyéticas Wintrobe 1999. p 2342-2365

  3. Leucemia Granulocítica Wintrobe 1999. p 2342-2365

  4. CitogenéticaCromosoma Philadelphia (Ph1) HENRY, 2001. p 602 y1356.

  5. HENRY, 2001. p 602 y1356.

  6. Cinasa de la Tirosina: Anormal Medicina universitaria .V 3, #12. 2001. p.120.

  7. Relevancia en el diagnóstico Wintrobe 1999. p 2342-2365

  8. Fases de la leucemia granulocítica * Entre ambas fases hay un intervalo promedio de 36 meses.

  9. Cuadro clínico: Fase Crónica Wintrobe 1999. p 2342-2365

  10. Leucemia Granulocítica

  11. Cuadro clínico: Fase Crónica Wintrobe 1999. p 2342-2365

  12. Fase Acelerada Fundamentos de hematología.2003.247-259.

  13. Tratamiento: Fase Crónica El principal objetivo es obtener: Fundamentos de hematología.2003.247-259.

  14. Criterios de remisión clínica Fundamentos de hematología.2003.247-259.

  15. Criterios de remisión citogenética

  16. Tratamiento: Fase Crónica Fundamentos de hematología.2003.247-259.

  17. Imatinib Medicina universitaria .V 3, #12. 2001. p.120.

  18. Tratamiento: Fase acelerada. Fundamentos de hematología.2003.247-259.

More Related